• Optimizing Assays with Atrial Natriuretic Peptide (ANP) (C49

  2026-07-03

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, focusing on the robust performance of Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat (SKU A1009). Researchers gain scenario-driven guidance on experimental design, protocol optimization, and product selection, with evidence-based recommendations and direct links to validated supplier resources.

• 3-Bromopyruvate and Cetuximab Co-Treatment Induces Ferroptos

  2026-07-02

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab overcomes intrinsic and acquired cetuximab resistance in colorectal cancer by activating autophagy-dependent ferroptosis and apoptosis. Mechanistic insights reveal the restoration of FOXO3a signaling as a key node, suggesting new intervention strategies for refractory CRC cases.

• Monomeric Amyloid Beta (1-40) Regulates Microglial Inflammat

  2026-07-02

  This study uncovers a previously unrecognized role for monomeric amyloid beta in suppressing microglial inflammatory activity via an APP and heterotrimeric G protein-dependent pathway. These insights reframe amyloid beta as a regulator of brain immune homeostasis and open new questions for Alzheimer's disease research.

• UTP Solution (100 mM): Molecular Precision for Monogenic Gen

  2026-07-01

  Explore how UTP Solution (100 mM), a high-purity uridine-5'-triphosphate trisodium salt, empowers advanced studies of monogenic receptor expression and epigenetic regulation. This in-depth guide uniquely connects nucleotide chemistry with cutting-edge insights from neural gene regulation research.

• AMG 487: Redefining CXCR3 Antagonism for Macrophage State Co

  2026-07-01

  Discover how AMG 487, a potent CXCR3 antagonist, uniquely modulates macrophage polarization beyond standard protocols. This deep dive integrates recent mechanistic breakthroughs to guide advanced assay design and interpretation.

• CTCF’s Role in Centromere Function and Mitotic Fidelity

  2026-06-30

  This article reviews recent findings on CTCF as an essential maintainer of centromere integrity and mitotic accuracy. Using rapid protein degradation, the study reveals that CTCF loss disrupts chromosomal organization and cell division, with implications for understanding mitotic errors and their links to disease.

• Triptolide (PG490): Precision Tools for Cancer & Immune Rese

  2026-06-30

  Triptolide (PG490), a research-grade transcriptional inhibitor from APExBIO, empowers advanced workflows in cancer and immunology with nanomolar potency and robust mechanistic validation. This article translates new reference findings and expert protocols into actionable guidance for maximizing reproducibility and sensitivity in cell-based and developmental models.

• Recombinant Mouse Macrophage Colony Stimulating Factor: Appl

  2026-06-29

  Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag empowers precise modeling of macrophage-driven processes, enabling advanced studies in fibrosis, immunology, and osteoclastogenesis. This guide delivers stepwise protocols, troubleshooting strategies, and translational insights rooted in the latest epigenetic findings, positioning APExBIO's validated reagent as an indispensable tool for robust, reproducible research.

• Metoprolol Tartrate: Precision β1 Blockade in Cardiovascular

  2026-06-29

  Metoprolol Tartrate enables targeted β1-adrenergic receptor inhibition, offering researchers high specificity for cardiovascular and hematopoietic models. This guide translates new mechanistic evidence and protocol enhancements into reliable experimental results, distinguishing Metoprolol Tartrate as the gold standard for selective β1 blockade.

• AEBSF.HCl: Enhancing Protease Inhibition in Necroptosis Assa

  2026-06-28

  AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) empowers researchers to precisely dissect serine protease-driven cell death, amyloid processing, and leukemic cell lysis. This guide translates the latest mechanistic insights into actionable workflows, troubleshooting, and advanced applications for reproducible, high-impact research.

• HyperScribe All in One mRNA Synthesis Kit: Workflow and Inno

  2026-06-27

  The HyperScribe All in One mRNA Synthesis Kit streamlines production of translationally competent, ARCA-capped, polyadenylated mRNA for advanced applications such as organ-targeted vaccines. Leveraging innovations from recent spleen-targeted immunotherapy research, this guide details best-practice protocols, troubleshooting, and performance tips to maximize mRNA yield and utility.

• GSK126 EZH2 Inhibitor: Advanced Protocols and Cancer Epigene

  2026-06-26

  GSK126 is transforming cancer epigenetics research and stem cell biology by enabling precise control of PRC2-mediated gene silencing. This guide delivers stepwise workflow enhancements, troubleshooting tips, and translational insights for effective use of GSK126 EZH2 inhibitor from APExBIO, bridging oncology with emerging applications in pluripotent stem cell self-renewal.

• Doxorubicin Hydrochloride: Experimental Workflows & Cardioto

  2026-06-26

  Doxorubicin hydrochloride (Adriamycin HCl) is not only a gold-standard for modeling cancer cell death but also a critical tool for dissecting chemotherapeutic cardiotoxicity. This guide details stepwise workflows, troubleshooting strategies, and highlights a novel antioxidant-based mitigation technique from current research.

• Reliable S-Phase Detection with EdU Imaging Kits (Cy3): Best

  2026-06-25

  This article provides an evidence-based, scenario-driven guide for leveraging EdU Imaging Kits (Cy3) (SKU K1075) in cell proliferation and genotoxicity assays. Through real-world laboratory scenarios, we demonstrate how this 5-ethynyl-2'-deoxyuridine imaging kit resolves reproducibility and workflow challenges in S-phase DNA synthesis measurement, supporting robust and interpretable data for biomedical researchers.

• ZIF8-Based Nanotheranostic Platform Enhances TNBC Therapy

  2026-06-25

  Li et al. introduce a multifunctional ZIF8-based nanoplatform for targeted, ultrasound-guided treatment of triple-negative breast cancer (TNBC), employing ciprofloxacin as both sonosensitizer and chemotherapeutic agent. Their approach integrates tumor-targeted delivery, pH-responsive drug release, and immune activation, offering a promising route for synergistic TNBC theranostics.

16083 records 1/1073 page Next 12345 下5页 Last page